MWNA
ALLO icon

Marshall Wace North America’s Allogene Therapeutics ALLO Stock Holding History

Marshall Wace North America’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-325,040
Closed -$8.48M – 1406
2021
Q2 		$8.48M Buy
+325,040
New +$9.27M 0.04% 408
2020
Q4 		– Sell
-13,878
Closed -$523K – 1285
2020
Q3 		$523K Buy
+13,878
New +$523K ﹤0.01% 956
2020
Q2 		– Sell
-149,235
Closed -$2.9M – 1135
2020
Q1 		$2.9M Sell
149,235
-43,823
-23% -$1.04M 0.02% 417
2019
Q4 		$5.02M Buy
+193,058
New +$5.32M 0.02% 389
2019
Q3 		– Sell
-9,531
Closed -$256K – 1294
2019
Q2 		$256K Sell
9,531
-230,529
-96% -$6.42M ﹤0.01% 1000
2019
Q1 		$6.94M Buy
+240,060
New +$6.97M 0.05% 261

Other funds holding ALLO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return